Deutsche Märkte geschlossen

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
90,99-1,86 (-2,00%)
Börsenschluss: 04:00PM EDT
90,99 0,00 (0,00%)
Nachbörse: 08:00PM EDT

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter19.800

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Bernard J. ZovighianCEO & Director2,27MN/A1968
Mr. Scott B. UllemCorporate VP & CFO1,35M6,36M1967
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development1,27M2,68M1962
Mr. Larry L. WoodCorporate VP and Group President of TAVR & Surgical Structural Heart1,49M2,13M1966
Mr. Andrew M. DahlPrincipal Accounting Officer, Senior VP & Corporate ControllerN/AN/A1977
Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Technology & Chief Scientific OfficerN/AN/AN/A
Mark WilterdingVice President of Investor RelationsN/AN/AN/A
Mr. Arnold A. PinkstonCorporate VP & General CounselN/AN/A1959
Mr. Dirksen J. LehmanCorporate Vice President of Public AffairsN/AN/AN/A
Ms. Christine Z. McCauleyCorporate Vice President of Human ResourcesN/AN/A1965
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Corporate Governance

Edwards Lifesciences Corporations ISS Governance QualityScore, Stand 1. Juli 2024, lautet 3. Die grundlegenden Scores sind Audit: 5, Vorstand: 4, Shareholderrechte: 3, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.